Global Hypersensitivity Market, By Types (Type I-Immediate Hypersensitivity, Type II- Cytotoxic Hypersensitivity, Type III- Immune-Complex, Type IV- Delayed Hypersensitivity, Others), Diseases (Urticaria, Eczema, Conjunctivitis, Rhinorrhea, Rhinitis, Asthma, Gastroenteritis, Systemic Lupus Erythematosus, Arthurs Reaction, Lupus Nephritis, Aspergillosis, Polyarteritis, Rheumatoid Arthritis, Tuberculosis, Leprosy, Blastomycosis, Histoplasmosis, Toxoplasmosis, Leishmaniasis, Others), Medication (Anti-Inflammatory, Immunosuppressive, Anti-Histamines, Corticosteroids Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Hypersensitivity Market Analysis and Size
For more than 50 years, the developed world has observed a rise in allergy illnesses. Allergies is found to be the sixth greatest cause of chronic illness in the U.S., and over 50 million Americans suffer from allergies every year. The global hypersensitivity market is expected to be boosted by growing allergic reactions such as air-borne, food allergy, and drug allergy, growing incidence of chronic allergic reaction illnesses, and continuing clinical advancement for hypersensitivity treatment.
Data Bridge Market Research analyses a growth rate in the global hypersensitivity market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hypersensitivity Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Types (Type I-Immediate Hypersensitivity, Type II- Cytotoxic Hypersensitivity, Type III- Immune-Complex, Type IV- Delayed Hypersensitivity, Others), Diseases (Urticaria, Eczema, Conjunctivitis, Rhinorrhea, Rhinitis, Asthma, Gastroenteritis, Systemic Lupus Erythematosus, Arthurs Reaction, Lupus Nephritis, Aspergillosis, Polyarteritis, Rheumatoid Arthritis, Tuberculosis, Leprosy, Blastomycosis, Histoplasmosis, Toxoplasmosis, Leishmaniasis, Others), Medication (Anti-Inflammatory, Immunosuppressive, Anti-Histamines, Corticosteroids Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc.(U.S.), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Amneal Pharmaceutical Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Hypersensitivity is the undesirable reaction the body immune system produces in defence to allergic or foreign material. Hypersensitivity reactions require a pre-sensitized state of the host. Hypersensitivity reactions may cause serious injuries, lifelong disorders and even death. Such conditions lead to difficulty for lungs to function well and may even damage the lungs permanently. The causes of hypersensitivity pneumonitis include, plant proteins, microbes, animals, organic and inorganic chemicals
Global Hypersensitivity Market Dynamics
Drivers
- Increased Sensitization Rates
According to the American Academy of allergy, Asthma & Immunology, in 2013, sensitization rates to one or more common allergens among school children was found to be 40%-50% roughly, worldwide. As per the World Allergy Organization, allergic rhinitis impacts 10% to 30% of the global population, whereas food allergies impact around 200 million people globally. This boost the market growth.
- Launch of New Drugs
Several industry participants focus more on the development of novel products to maintain a competitive edge. For instance, in October 2019, Stallergenes Greer Ltd. collaborated with Anergis, a Switzerland-based clinical-stage biopharma company, to start a research study focused on the evaluation of the second-generation contiguous overlapping peptides allergen immunotherapy for birch pollen allergy. This boosts the market growth
Opportunities
- Increasing Demand for Retail Pharmacies
The rise in the number of rhinitis therapeutics delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Rising Healthcare Expenditure
Since the last few decades, it has been witnessed that global per capita healthcare spending has improved considerably due to rising rate of awareness associated with the availability of treatments and diagnostic methods for treating various diseases. More and more healthcare spending is likely to result in increasing demand for better diagnostic methods, which in turn, create high growth opportunities for market players operating in the treatment of allergic and asthmatic conditions in the global hypersensitivity market.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global hypersensitivity market over a forecast period.
- High Cost
The huge expenditure associated with the treatment of hypersensitivity hamper the market growth. Several immunosuppresants, corticosteroids and anti-histamines that are costly and are difficult to afford by many of the people. Thus, it impedes the market growth.
This global hypersensitivity market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hypersensitivity market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hypersensitivity Market Scope
The global hypersensitivity market is segmented on the basis of types, diseases, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Types
- Type I-Immediate Hypersensitivity
- Type II- Cytotoxic Hypersensitivity
- Type III- Immune-Complex
- Type IV- Delayed Hypersensitivity
- Others
Diseases
- Urticaria
- Rhinorrhea
- Rhinitis
- Asthma
- Gastroenteritis
- Systemic Lupus Erythematosus
- Arthurs Reaction
- Lupus Nephritis
- Aspergillosis
- Polyarteritis
- Rheumatoid Arthritis
- Tuberculosis
- Leprosy
- Blastomycosis
- Histoplasmosis
- Toxoplasmosis
- Leishmaniasis
- Others
Treatment
- Anti-Inflammatory
- Immunosuppressive
- Anti-Histamines
- Corticosteroids
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Hypersensitivity Market Regional Analysis/Insights
The global hypersensitivity market is analyzed and market size insights and trends are provided by types, diseases, treatment, distribution channel and end-user as referenced above.
The major countries covered in the global hypersensitivity market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for global hypersensitivity market throughout the forecasted period due to increased government awareness programs, increased prevalence of asthma, skin allergy and tuberculosis and presence of the generic manufacturer.
North America dominates the market due to the presence of key manufacture of the product and increased prevalence of lupus diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Hypersensitivity Market Share Analysis
The global hypersensitivity market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hypersensitivity market
Key players operating in the global hypersensitivity market include:
- Pfizer Inc.(U.S.)
- Merck KGaA (Germany)
- Sanofi (France)
- Biocare Medical, LLC (U.S.)
- Lilly (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- GSK plc. (U.K.)
- Bayer AG (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Lilly (U.S.)
- AstraZeneca (U.K.)
- AbbVie Inc (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd (India)
- Endo International plc (Ireland)
- Amneal Pharmaceutical Inc (U.S.)
SKU-